ABSTRACT Serum antibodies against human T cell leukaemia virus type
Several methods to detect antibodies against HTLV-I-namely, indirect immunofluorescence using fixed MT-I cells,' membrane immunofluorescence, solid phase immunocompetition assay,23 enzyme linked immunosorbent assay (ELISA),4 gelatin particle agglutination,5 and strip radioimmunoassay, based on the Western blotting assay,6 have been reported. There are still difficulties, however, in detecting specific anti-HTLV-I antibodies in patients with autoimmune disease with circulating autoantibodies. Indeed, with indirect immunofluorescence and ELISA assays it is not always easy to exclude a non-specific reaction. In this study we investigated the presence of antibodies to HTLV-I in the sera from patients with systemic lupus erythematosus and other autoimmune diseases by several of the above methods and a new immunoperoxidase technique.
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PATIENTS WITH AUTOIMMUNE DISEASE
Sera from seven patients with systemic lupus erythematosus and five patients with progressive systemic sclerosis (n = 1), idiopathic thrombocytopenic purpura (n = 1), Sj6gren's syndrome (n = 1), polymyositis, (n = 1), and rheumatoid arthritis (n = 1), treated in Kumamoto (an area where the incidence of HTLV-I infection is high) were studied. All were women aged between 28 and 67 years who had one or. more circulating autoantibodies (anti-DNA, antimitochondria, thyroid autoantibodies etc). As positive controls, sera from 16 patients with adult T cell leukaemia (ATL) and 19 HTLV-I carriers were tested by indirect immunofluorescence, and sera from 26 healthy subjects were used as negative controls. I (TdT), may be useful and more specific than indirect immunofluorescence and ELISA to detect antibodies to HTLV-I. Thus sera from all six patients which showed a non-specific reaction for HTLV-I antibodies when assessed by indirect immunofluorescence or ELISA, or both, were shown to be unreactive with the indirect immunoperoxidase staining method. The indirect immunoperoxidase staining method always showed clearly granular positive patterns in sera from patients with ATL and in HTLV-I carriers. These results were further confirmed by the Western blotting assay.
A similar indirect immunoperoxidase staining method has previously been reported to be useful in detecting the presence of antibody to HTLV-III,'5 and it has been shown that results obtained by indirect immunoperoxidase staining are comparable with those of the indirect immunofluorescence method. The indirect immunoperoxidase staining method, however, has not been applied systematically to investigate sera from patients with autoantibodies, which may show a non-specific pattern of reactivity by indirect immunofluorescence and the ELISA methods. In this study we have shown that the indirect immunoperoxidase staining method may be more specific than the indirect immunofluorescence and ELISA methods as, unlike indirect immunofluorescence and ELISA, a non-specific reaction has not been detected by indirect immunoperoxidase staining. In relation to the ELISA assay, we performed the standard ELISA test by an antiglobulin technique; it is possible, however, that a competitive ELISA technique might avoid some of the difficulties (non-specific staining) derived from the standard ELISA test and therefore might be as specific as the indirect immunoperoxidase staining method. We have also shown that indirect immunoperoxidase staining is equally sensitive for testing samples of HTLV-Ipositive subjects (healthy carriers and ATL patients). In fact, the indirect immunoperoxidase staining method described here seems to be reliable, relatively simple, and reproducible, and can be used as a first line screening method for HTLV-I antibody.
Although a role for viruses in the aetiology of systemic lupus erythematosus has been regarded as feasible,'7 the role of HTLV-I has not been confirmed.'8 Our data further suggest that HTLV-I does not play a part in the pathogenesis of systemic lupus erythematosus.
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